BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 25347470)

  • 1. Ketogenesis prevents diet-induced fatty liver injury and hyperglycemia.
    Cotter DG; Ercal B; Huang X; Leid JM; d'Avignon DA; Graham MJ; Dietzen DJ; Brunt EM; Patti GJ; Crawford PA
    J Clin Invest; 2014 Dec; 124(12):5175-90. PubMed ID: 25347470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic ketogenic insufficiency reprograms hepatic glycogen metabolism and the lipidome.
    d'Avignon DA; Puchalska P; Ercal B; Chang Y; Martin SE; Graham MJ; Patti GJ; Han X; Crawford PA
    JCI Insight; 2018 Jun; 3(12):. PubMed ID: 29925686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of peripheral ketolytic deficiency on hepatic ketogenesis and gluconeogenesis during the transition to birth.
    Cotter DG; Ercal B; d'Avignon DA; Dietzen DJ; Crawford PA
    J Biol Chem; 2013 Jul; 288(27):19739-49. PubMed ID: 23689508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hmgcs2-mediated ketogenesis modulates high-fat diet-induced hepatosteatosis.
    Asif S; Kim RY; Fatica T; Sim J; Zhao X; Oh Y; Denoncourt A; Cheung AC; Downey M; Mulvihill EE; Kim KH
    Mol Metab; 2022 Jul; 61():101494. PubMed ID: 35421611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired ketogenesis and increased acetyl-CoA oxidation promote hyperglycemia in human fatty liver.
    Fletcher JA; Deja S; Satapati S; Fu X; Burgess SC; Browning JD
    JCI Insight; 2019 Apr; 5(11):. PubMed ID: 31012869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impairments of hepatic gluconeogenesis and ketogenesis in PPARα-deficient neonatal mice.
    Cotter DG; Ercal B; d'Avignon DA; Dietzen DJ; Crawford PA
    Am J Physiol Endocrinol Metab; 2014 Jul; 307(2):E176-85. PubMed ID: 24865983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acyl-Coenzyme A Thioesterase 9 Traffics Mitochondrial Short-Chain Fatty Acids Toward De Novo Lipogenesis and Glucose Production in the Liver.
    Steensels S; Qiao J; Zhang Y; Maner-Smith KM; Kika N; Holman CD; Corey KE; Bracken WC; Ortlund EA; Ersoy BA
    Hepatology; 2020 Sep; 72(3):857-872. PubMed ID: 32498134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NAFLD: Ketogenesis could be a determinant of steatohepatitis.
    Patman G
    Nat Rev Gastroenterol Hepatol; 2014 Dec; 11(12):702. PubMed ID: 25385228
    [No Abstract]   [Full Text] [Related]  

  • 9. The mitochondrial pyruvate carrier mediates high fat diet-induced increases in hepatic TCA cycle capacity.
    Rauckhorst AJ; Gray LR; Sheldon RD; Fu X; Pewa AD; Feddersen CR; Dupuy AJ; Gibson-Corley KN; Cox JE; Burgess SC; Taylor EB
    Mol Metab; 2017 Nov; 6(11):1468-1479. PubMed ID: 29107293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Branched chain amino acids and carbohydrate restriction exacerbate ketogenesis and hepatic mitochondrial oxidative dysfunction during NAFLD.
    Muyyarikkandy MS; McLeod M; Maguire M; Mahar R; Kattapuram N; Zhang C; Surugihalli C; Muralidaran V; Vavilikolanu K; Mathews CE; Merritt ME; Sunny NE
    FASEB J; 2020 Nov; 34(11):14832-14849. PubMed ID: 32918763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipotoxicity in steatohepatitis occurs despite an increase in tricarboxylic acid cycle activity.
    Patterson RE; Kalavalapalli S; Williams CM; Nautiyal M; Mathew JT; Martinez J; Reinhard MK; McDougall DJ; Rocca JR; Yost RA; Cusi K; Garrett TJ; Sunny NE
    Am J Physiol Endocrinol Metab; 2016 Apr; 310(7):E484-94. PubMed ID: 26814015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyruvate-Carboxylase-Mediated Anaplerosis Promotes Antioxidant Capacity by Sustaining TCA Cycle and Redox Metabolism in Liver.
    Cappel DA; Deja S; Duarte JAG; Kucejova B; Iñigo M; Fletcher JA; Fu X; Berglund ED; Liu T; Elmquist JK; Hammer S; Mishra P; Browning JD; Burgess SC
    Cell Metab; 2019 Jun; 29(6):1291-1305.e8. PubMed ID: 31006591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Forkhead Box O6 (FoxO6) Depletion Attenuates Hepatic Gluconeogenesis and Protects against Fat-induced Glucose Disorder in Mice.
    Calabuig-Navarro V; Yamauchi J; Lee S; Zhang T; Liu YZ; Sadlek K; Coudriet GM; Piganelli JD; Jiang CL; Miller R; Lowe M; Harashima H; Dong HH
    J Biol Chem; 2015 Jun; 290(25):15581-15594. PubMed ID: 25944898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Pyruvate Dehydrogenase Kinase 2 Protects Against Hepatic Steatosis Through Modulation of Tricarboxylic Acid Cycle Anaplerosis and Ketogenesis.
    Go Y; Jeong JY; Jeoung NH; Jeon JH; Park BY; Kang HJ; Ha CM; Choi YK; Lee SJ; Ham HJ; Kim BG; Park KG; Park SY; Lee CH; Choi CS; Park TS; Lee WN; Harris RA; Lee IK
    Diabetes; 2016 Oct; 65(10):2876-87. PubMed ID: 27385159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NFE2 Induces miR-423-5p to Promote Gluconeogenesis and Hyperglycemia by Repressing the Hepatic FAM3A-ATP-Akt Pathway.
    Yang W; Wang J; Chen Z; Chen J; Meng Y; Chen L; Chang Y; Geng B; Sun L; Dou L; Li J; Guan Y; Cui Q; Yang J
    Diabetes; 2017 Jul; 66(7):1819-1832. PubMed ID: 28411267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Out of the frying pan: dietary saturated fat influences nonalcoholic fatty liver disease.
    Parks E; Yki-Järvinen H; Hawkins M
    J Clin Invest; 2017 Feb; 127(2):454-456. PubMed ID: 28112684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin B5 and N-Acetylcysteine in Nonalcoholic Steatohepatitis: A Preclinical Study in a Dietary Mouse Model.
    Machado MV; Kruger L; Jewell ML; Michelotti GA; Pereira Tde A; Xie G; Moylan CA; Diehl AM
    Dig Dis Sci; 2016 Jan; 61(1):137-48. PubMed ID: 26403427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of ketone signaling in the hepatic response to fasting.
    Geisler CE; Ghimire S; Bogan RL; Renquist BJ
    Am J Physiol Gastrointest Liver Physiol; 2019 May; 316(5):G623-G631. PubMed ID: 30767679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise in mice ameliorates high-fat diet-induced nonalcoholic fatty liver disease by lowering HMGCS2.
    Qian X; Wang T; Gong J; Wang L; Chen X; Lin H; Tu W; Jiang S; Li S
    Aging (Albany NY); 2021 Mar; 13(6):8960-8974. PubMed ID: 33647884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-obesogenic effects of WY14643 (PPAR-alpha agonist): Hepatic mitochondrial enhancement and suppressed lipogenic pathway in diet-induced obese mice.
    Veiga FMS; Graus-Nunes F; Rachid TL; Barreto AB; Mandarim-de-Lacerda CA; Souza-Mello V
    Biochimie; 2017 Sep; 140():106-116. PubMed ID: 28711683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.